Organization W h e n things are well under way, difficulties as to structure and continuity begin to appear
Now, Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes
GHK-Cu GHK-Cu is one of the most well-researched copper peptides for hair growth, known for its ability to stimulate follicle regeneration and support healthier, thicker strands
How do I stay young and healthy with collagen
First description in humans of the ability of SGLT2 inhibitors to attenuate glomerular hyperfiltration, likely by affecting tubuloglomerular feedback mechanisms
Brian VanderBeek, associate professor of ophthalmology at the Hospital of the University of Pennsylvania